Products & Services · Year Ten

Multi-line and other specialty — Year Ten

Arch Capital Group Multi-line and other specialty — Year Ten decreased by 71.4% to 0.4% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 71.4%, from 1.4% to 0.4%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

Strong performance at the ten-year mark demonstrates a mature, well-managed segment with sustainable competitive advantages.

Detailed definition

This metric represents the financial performance of the multi-line and specialty insurance segment for the tenth year of...

Peer comparison

Comparable to decade-long segment performance analysis provided by established insurance and reinsurance market participants.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_ten

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value-0.1%0%0.5%1.4%0.4%
QoQ Change+100.0%+180.0%-71.4%
YoY Change+100.0%+180.0%-71.4%
Range-0.1%1.4%
CAGR+300.0%
Avg YoY Growth+69.5%
Median YoY Growth+100.0%

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year ten?
Arch Capital Group (ACGL) reported multi-line and other specialty — year ten of 0.4% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year ten changed year-over-year?
Arch Capital Group's multi-line and other specialty — year ten decreased by 71.4% year-over-year, from 1.4% to 0.4%.
What does multi-line and other specialty — year ten mean?
The financial performance of the multi-line and specialty insurance segment in the tenth year of the reporting period.